Literature DB >> 15664142

Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles.

Yung-Chih Kuo1.   

Abstract

Loading efficiency (LE) of stavudine (D4T), a human immunodeficiency antiretroviral agent, on the external surfaces of polybutylcyanoacrylate (PBCA) and methylmethacrylate-sulfopropylmethacrylate (MMA-SPM) was investigated. The experimental results indicate that the larger the polymeric nanoparticles (NPs), the smaller LE of D4T on the two kinds of biomaterials. Freeze drying of the two NPs, however, yields an increase in particle size and an increase in LE of D4T, in general. Preservation of the two D4T-loaded NPs through cold storage at 4 degrees C over 6 weeks leads to an increase in particle size and a decrease in LE of D4T. LE of D4T on both of the two NPs decreases with a variation in pH value from pH 7.2 of loading medium. LE of D4T on MMA-SPM NPs is larger than that on PBCA NPs at pH 7.4; and for the case of variation in pH value of loading medium from pH 7.2, the extent of decrease in LE of D4T for MMA-SPM NPs is higher than that on PBCA NPs. These outcomes imply that for oral administration, D4T-loaded MMA-SPM NPs may be more advantageous than D4T-loaded PBCA NPs, and D4T-loaded PBCA NPs may be more favorable than D4T-loaded MMA-SPM NPs for intravenous injection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664142     DOI: 10.1016/j.ijpharm.2004.11.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice.

Authors:  Christopher J Destache; Todd Belgum; Michael Goede; Annemarie Shibata; Michael A Belshan
Journal:  J Antimicrob Chemother       Date:  2010-08-21       Impact factor: 5.790

Review 2.  Polymeric nanogel formulations of nucleoside analogs.

Authors:  Serguei V Vinogradov
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

3.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors:  Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

Review 4.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09

Review 5.  Nano-ART and NeuroAIDS.

Authors:  Malay K Das; Anupam Sarma; Tapash Chakraborty
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 6.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

Review 7.  Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.

Authors:  Madhavan Nair; Rahul Dev Jayant; Ajeet Kaushik; Vidya Sagar
Journal:  Adv Drug Deliv Rev       Date:  2016-03-02       Impact factor: 15.470

Review 8.  Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.

Authors:  Catherine DeMarino; Angela Schwab; Michelle Pleet; Allison Mathiesen; Joel Friedman; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-02       Impact factor: 4.147

9.  Brain-Derived Neurotrophic Factor Loaded PS80 PBCA Nanocarrier for In Vitro Neural Differentiation of Mouse Induced Pluripotent Stem Cells.

Authors:  Chiu-Yen Chung; Martin Hsiu-Chu Lin; I-Neng Lee; Tsong-Hai Lee; Ming-Hsueh Lee; Jen-Tsung Yang
Journal:  Int J Mol Sci       Date:  2017-03-19       Impact factor: 5.923

10.  Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.

Authors:  Christopher J Destache; Todd Belgum; Keith Christensen; Annemarie Shibata; Akhilesh Sharma; Alekha Dash
Journal:  BMC Infect Dis       Date:  2009-12-09       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.